






























































the bmj | BMJ 2021;372:n604 | doi: 10.1136/bmj.n604 1
RESEARCH
Associations of healthy lifestyle and socioeconomic status with 
mortality and incident cardiovascular disease: two prospective 
cohort studies
Yan-Bo Zhang,1 Chen Chen,1,2 Xiong-Fei Pan,1,3 Jingyu Guo,4 Yanping Li,5 Oscar H Franco,6  
Gang Liu,7 An Pan1
ABSTRACT
OBJECTIVE
To examine whether overall lifestyles mediate 
associations of socioeconomic status (SES) with 
mortality and incident cardiovascular disease (CVD) 
and the extent of interaction or joint relations of 
lifestyles and SES with health outcomes.
DESIGN
Population based cohort study.
SETTING
US National Health and Nutrition Examination Survey 
(US NHANES, 1988-94 and 1999-2014) and UK 
Biobank.
PARTICIPANTS
44 462 US adults aged 20 years or older and 399 537 
UK adults aged 37-73 years.
EXPOSURES
SES was derived by latent class analysis using family 
income, occupation or employment status, education 
level, and health insurance (US NHANES only), and 
three levels (low, medium, and high) were defined 
according to item response probabilities. A healthy 
lifestyle score was constructed using information 
on never smoking, no heavy alcohol consumption 
(women ≤1 drink/day; men ≤2 drinks/day; one drink 
contains 14 g of ethanol in the US and 8 g in the 
UK), top third of physical activity, and higher dietary 
quality.
MAIN OUTCOME MEASURES
All cause mortality was the primary outcome in both 
studies, and CVD mortality and morbidity in UK 
Biobank, which were obtained through linkage to 
registries.
RESULTS
US NHANES documented 8906 deaths over a mean 
follow-up of 11.2 years, and UK Biobank documented 
22 309 deaths and 6903 incident CVD cases over 
a mean follow-up of 8.8-11.0 years. Among adults 
of low SES, age adjusted risk of death was 22.5 
(95% confidence interval 21.7 to 23.3) and 7.4 (7.3 
to 7.6) per 1000 person years in US NHANES and 
UK Biobank, respectively, and age adjusted risk 
of CVD was 2.5 (2.4 to 2.6) per 1000 person years 
in UK Biobank. The corresponding risks among 
adults of high SES were 11.4 (10.6 to 12.1), 3.3 
(3.1 to 3.5), and 1.4 (1.3 to 1.5) per 1000 person 
years. Compared with adults of high SES, those 
of low SES had higher risks of all cause mortality 
(hazard ratio 2.13, 95% confidence interval 1.90 
to 2.38 in US NHANES; 1.96, 1.87 to 2.06 in UK 
Biobank), CVD mortality (2.25, 2.00 to 2.53), and 
incident CVD (1.65, 1.52 to 1.79) in UK Biobank, 
and the proportions mediated by lifestyle were 
12.3% (10.7% to 13.9%), 4.0% (3.5% to 4.4%), 
3.0% (2.5% to 3.6%), and 3.7% (3.1% to 4.5%), 
respectively. No significant interaction was observed 
between lifestyle and SES in US NHANES, whereas 
associations between lifestyle and outcomes were 
stronger among those of low SES in UK Biobank. 
Compared with adults of high SES and three or four 
healthy lifestyle factors, those with low SES and no 
or one healthy lifestyle factor had higher risks of all 
cause mortality (3.53, 3.01 to 4.14 in US NHANES; 
2.65, 2.39 to 2.94 in UK Biobank), CVD mortality 
(2.65, 2.09 to 3.38), and incident CVD (2.09, 1.78 to 
2.46) in UK Biobank.
CONCLUSIONS
Unhealthy lifestyles mediated a small proportion 
of the socioeconomic inequity in health in both 
US and UK adults; therefore, healthy lifestyle 
promotion alone might not substantially reduce 
the socioeconomic inequity in health, and other 
measures tackling social determinants of health 
are warranted. Nevertheless, healthy lifestyles were 
associated with lower mortality and CVD risk in 
different SES subgroups, supporting an important 
role of healthy lifestyles in reducing disease 
burden.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Disadvantaged socioeconomic status (SES) and unhealthy lifestyles have been 
associated with higher risks of mortality and incident cardiovascular disease 
(CVD)
Studies found that individual lifestyle factors might mediate the associations 
between single socioeconomic factors and health; however, the results are 
not consistent, and to what extent lifestyle factors mediate the associations of 
overall SES with mortality and incident CVD remains unclear
Little is known about the interaction and joint associations of lifestyles and SES 
with mortality and incident CVD
WHAT THIS STUDY ADDS
In two nationwide cohort studies in US and UK adults, those of low SES had 
higher risks of mortality and CVD, and overall lifestyle only explained 3.0% to 
12.3% of the excess risks
Significant interactions were found between lifestyle factors and SES on 
mortality and incident CVD in UK adults, and the associations between healthy 
lifestyles and outcomes were stronger among those of low SES
Compared with those of high SES and the healthiest lifestyle, those of low SES 
and the least healthy lifestyle had 2.09-fold to 3.53-fold risks of mortality and 
incident CVD
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Introduction
Socioeconomic status (SES) has been associated with 
differences in morbidity and mortality.1 Although most 
countries and regions have witnessed socioeconomic 
progress and rising standards of living in recent 
decades, the US and UK are the top two countries 
showing an increasing rate of wealth inequity 
among Organization for Economic Cooperation and 
Development countries.2 Moreover, the gap has 
also become more pronounced for socioeconomic 
inequity in survival—longevity has increased among 
Americans with middle and high income, whereas in 
poor Americans it has remained unchanged or even 
decreased in certain demographic groups.3 Similar 
trends are also observed in the UK.2 The impacts of 
these differences have been made more evident during 
the covid-19 pandemic, which has affected socially 
disadvantaged groups the most.4 Immediate efforts 
are therefore warranted to reduce socioeconomic 
inequities in health and to improve the resilience of 
populations.
Lifestyle factors are commonly viewed as mediators 
between SES and health and that healthy lifestyles 
might alleviate the socioeconomic inequities in health.5 
Multiple studies have examined the contribution of an 
individual lifestyle factor or several in the association 
between SES and mortality or morbidity.6 However, 
important gaps remain. First, how much an overall 
lifestyle mediates the association between SES and 
health outcomes is debatable. Previous studies 
tended to use single variables (eg, income, wealth, 
occupation, education level) to represent individual 
level SES,6 which only partly reflected overall SES7; 
thus it is essential to construct a comprehensive SES 
variable comprising different aspects of SES. Besides, 
lifestyle factors are interrelated8 and few studies have 
built a healthy lifestyle score to reflect overall lifestyle 
and to evaluate its impact on the socioeconomic 
inequities in health. Second, limited research has been 
performed on the interaction and joint associations of 
SES and overall lifestyles with health outcomes. Third, 
it remains unclear whether the findings are consistent 
among subpopulations of different age, sex, and racial 
or ethnic groups.
We used data from the US National Health and 
Nutrition Examination Survey (US NHANES) and UK 
Biobank to evaluate the complex relations of lifestyles 




US NHANES recruited a representative sample of 
civilian, community dwelling members of the US 
population using a complex, multistage probability 
design. The survey was conducted periodically before 
1999 and continuously thereafter. Details of the study 
design and data collection have been previously 
described.9 Although US NHANES has released cross 
sectional questionnaire, examination, and laboratory 
data up to 2018, mortality data were updated to 31 
December 2015. Accordingly, the current analysis 
included 61 202 participants who were aged 20 
years and older and not pregnant at baseline in US 
NHANES III (1988-94) and continuous NHANES 
(1999-2014) surveys. Those with missing information 
on socioeconomic factors (n=6939), lifestyle factors 
(n=8156), other covariates (n=1619), and deaths 
(n=26) were excluded from the analysis. Overall, 
44 462 participants from US NHANES were included 
(supplementary fig 1).
UK Biobank recruited more than 500 000 parti-
cipants aged 37 to 73 years from 22 assessment 
centers across England, Scotland, and Wales between 
2007 and 2010. Details of the study design and data 
collection have been described previously.10 Among the 
502 492 participants, we excluded those with missing 
information on socioeconomic factors (n=77 962), 
lifestyle factors (n=20 029), and other covariates 
(n=4964). Overall, 399 537 participants were included 
(supplementary fig 1). For the analysis of incident 
CVD, we only included those without prevalent CVD 
(n=324 517) at baseline.
Assessment of SES
In US NHANES, self-reported family income level, 
occupation, education level, and health insurance 
were used to measure SES according to previous 
studies,7 11 and each factor was divided into three 
levels (low, medium, and high) with consideration of 
practical interpretation and sample size within levels. 
The family income level was operationalized using 
the family poverty to income ratio, which reflected the 
annual family income relative to the federal poverty 
level and was comparable across surveys since income 
thresholds were updated for inflation and family size 
each year.12 According to a published study and the 
Patient Protection and Affordable Care Act, we grouped 
participants according to the poverty to income ratio: 
low (≤1), middle (1-4), and high (≥4).12 Education was 
categorized into less than high school diploma, high 
school graduate or equivalent, and college or above.13 
Occupation was classified based on the widely used 
socioeconomic index in the US,14 and each occupation 
was rated according to the employees’ earnings, 
education level, and prestige. The socioeconomic 
index ranged between 13.98 and 90.45,15 and 
occupation was categorized into upper (socioeconomic 
index ≥50), lower (socioeconomic index <50, including 
retirees16 and students), and unemployment. Health 
insurance was categorized into private health 
insurance (including any private health insurance, 
Medi-Gap, or single-service plan), public health 
insurance only (including Medicare, Medicaid, State 
Children’s Healthcare Plan, military healthcare, Indian 
Health Service, State Sponsored Health Plan, or other 
government programme), and no health insurance.17 
An overall SES variable was created using latent class 
analysis based on family income level, occupation, 
education level, and health insurance (each factor had 
three levels).7 The latent class analysis, which uses 
multiple observed categorical variables to generate an 
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unmeasured variable (ie, latent variable) with a set of 
mutually exclusive latent classes, was conducted using 
PROC LCA, a new SAS procedure.18 Three latent classes 
were identified, which respectively represented a high, 
medium, and low SES according to the item-response 
probabilities.19 The supplementary file describes the 
data collection and latent class analysis in US NHANES.
In UK Biobank, total household income before tax 
was obtained through questionnaires, and partici-
pants could choose an option from <£18 000 ($25 000; 
€21 000), £18 000-£30 999, £31 000-£51 999, 
£52 000-£100 000, >£100 000, do not know, or prefer 
not to answer. A total of 14.3% of participants chose 
the last two options and were excluded from the main 
analyses as missing values; however, we included 
them in sensitivity analyses when evaluating single 
socioeconomic factors, consistent with a previous 
study,20 on the basis that these participants might be 
more likely to have lower SES. Participants reported 
their education qualifications as college or university 
degree; A levels, AS levels, or equivalent; O levels, 
GCSEs, or equivalent; CSEs or equivalent; NVQ, HND, 
HNC, or equivalent; other professional qualifications; 
none of the above (equivalent to less than high 
school diploma); or prefer not to answer (which was 
excluded from our analyses as missing values). As UK 
Biobank only acquired employment status instead of 
information on specific occupation at baseline, we 
regrouped participants into two groups: employed 
(including those in paid employment or self-employed, 
retired, doing unpaid or voluntary work, or being full 
or part time students) and unemployed. Because the 
National Health Service, a publicly funded healthcare 
system aiming to provide comprehensive, universal 
and free services, is implemented in the UK,21 we 
did not consider health insurance as a component 
of SES in UK Biobank. An overall SES variable was 
created using latent class analysis based on three 
individual socioeconomic factors (household income, 
education level, and employment status). We did not 
regroup household income and education level into 
three groups as we did in US NHANES because of the 
larger sample size in UK Biobank and failure of model 
convergence owing to fewer observed groups if the 
two variables were regrouped. Three latent classes 
were identified, which respectively represented a high, 
medium, and low SES according to the item-response 
probabilities. Details are reported in the supplementary 
file.
In UK Biobank, Townsend deprivation index 
was available as an area level SES variable derived 
from national census data according to postcodes 
of residence, which considered car ownership, 
household overcrowding, owner occupation, and 
unemployment.22 A higher Townsend deprivation 
index denotes lower area level SES.22
Assessment of lifestyle factors and other covariates
Since multiple lifestyle factors are interrelated and 
are associated with mortality and morbidity, we 
constructed a healthy lifestyle score including cigarette 
smoking, alcohol consumption, physical activity, 
and diet according to a previous US NHANES study23 
and that coincided with recommendations from the 
World Health Organization.24 All lifestyle factors were 
obtained through structured questionnaires and 24 
hour dietary recalls. Never smoking was considered as 
a healthy level, which was defined in the questionnaire 
as smoking fewer than 100 cigarettes in life. Frequency 
and volume of current alcohol consumption were self-
reported, and a healthy level was defined as daily 
consumption of one drink or fewer for women and 
two drinks or fewer for men, according to the dietary 
guidelines in the US and UK (one drink contains 14 g 
of ethanol in the US and 8 g in the UK).25 26 For physical 
activity, different assessment questions were used 
between the US and UK studies, and questionnaires 
also varied in different survey years in US NHANES. 
Nevertheless, weekly metabolic equivalent hours 
of leisure time physical activity were calculated in 
US NHANES 1999-2014 and UK Biobank, whereas 
monthly frequency of leisure time physical activity was 
calculated in US NHANES 1988-94. To harmonize the 
data, we further classified the participants into thirds 
and defined the top third as a healthy level of physical 
activity.
In US NHANES, dietary quality was obtained from 
24 hour dietary recalls and was assessed by healthy 
eating index (HEI) scores. The HEI-2015 was calculated 
for the 1999-2014 survey cycles, which aligns with the 
2015-20 Dietary Guidelines for Americans.27 However, 
because food codes used in the 1988-94 cycles could 
not match those used in the 1999-2014 cycles, we used 
HEI-1995 for the 1988-94 cycles and the variable was 
directly provided by the original dataset. HEI-1995 
aligns with the food guide pyramid released by the US 
Department of Agriculture in 1992.27 Supplementary 
table 1 provides details of constructions of HEI-1995 
and HEI-2015, and both scores reflected the overall 
dietary quality according to the contemporary dietary 
guidelines. A healthy diet was defined as the health 
eating index in the top two fifths of distribution.28 
In UK Biobank, dietary information was obtained 
through questionnaires and did not contain energy 
or salt intakes, thus we could not calculate the HEI 
scores. Instead, according to a previous UK Biobank 
study,29 we evaluated dietary quality using a more 
recent dietary recommendation for cardiovascular 
health, which considered adequate consumption of 
fruit, vegetables, whole grains, fish, shellfish, dairy 
products, and vegetable oils and reduced consumption 
of refined grains, processed meats, unprocessed 
meats, and sugar sweetened beverages. We defined 
a healthy diet as meeting at least five items of the 
recommendations (see supplementary table 2).
For each lifestyle factor, we assigned 1 point for 
a healthy level and 0 points for an unhealthy level. 
Thus, the healthy lifestyle score was the sum of the 
points and ranged between 0 and 4, with higher 
scores indicating healthier lifestyles. Although this 
simple additive method has been used widely,30-32 
the underlying assumption is that the associations 
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between different lifestyle factors and the outcome 
were identical, which might not be true. Thus we 
also constructed a weighted lifestyle score, where 
each lifestyle factor was weighted by its association 
with the outcome. Body mass index (BMI) was not 
included in the lifestyle score given the concern 
that it could be an intermediate factor between 
behavioral factors and health outcomes. In addition, 
the obesity paradox is a concern,33 and overweight 
and obesity might not be strongly associated with 
mortality in older people.13 Nevertheless, we also 
included baseline BMI in the lifestyle score in a 
sensitivity analysis, and healthy bodyweight was 
defined as a BMI of 18.5-24.9.28
Other covariates were obtained through question-
naires, including age; sex; marital status (US NHANES 
only); assessment centers (UK Biobank only); self-
reported race; an acculturation score based on the 
country of birth, length of time in the US or UK, and 
language spoken at home (see supplementary file);34 
history of hypertension, diabetes, CVD, or cancer; and 
history of chronic bronchitis, emphysema, or chronic 
obstructive pulmonary disease (UK Biobank only). 
Diagnoses of CVD and cancer were also obtained 
through linked hospital admissions data and cancer 
registry in the UK Biobank. Bodyweight and height 
were measured at baseline, with BMI calculated as 
weight (kg)/(height (m)2).
Outcome ascertainment
Outcomes were classified using ICD-9 and ICD-10 
(international classification of diseases, ninth and 10th 
revisions, respectively) codes. The primary outcomes 
included all cause mortality, CVD mortality, and 
incident CVD. In US NHANES, deaths were obtained 
through the National Death Index to 31 December 
2015.35 In UK Biobank, deaths were obtained through 
death certificates held within the NHS Information 
Centre (England and Wales) and the NHS Central 
Register (Scotland) to 30 April 2020.36 CVD diagnoses, 
including myocardial infarction (ICD-9 codes 410-412 
and 429.79; ICD-10 codes I21-I23, I24.1, and I25.2) 
and stroke diagnoses (ICD-9 codes 430, 431, 434, 
and 436; ICD-10 codes I60, I61, I63, and I64), were 
obtained through linked hospital admissions data 
including Hospital Episode Statistics-Admitted Patient 
Care (England), Scottish Morbidity Records-General/
Acute Inpatient and Day Case Admissions (Scotland), 
and Patient Episode Database for Wales as well as 
death register data to 31 January 2018.37 38 Secondary 
outcomes were mortality from heart disease (ICD-10 
codes I00-I09, I11, I13, and I20-I51 in US NHANES), 
coronary heart disease (ICD-10 codes I20-I25 in UK 
Biobank), and stroke (ICD-10 codes I60, I61, I63, and 
I64 in UK Biobank), as well as incident myocardial 
infarction and stroke. Mortality from cerebrovascular 
disease or total CVD was not considered in NHANES 
because the US National Death Index matched 
mortality dataset stopped updating data on deaths 
from cerebrovascular diseases after 31 December 
2011.
Statistical analysis
To estimate appropriate variance and statistics 
representative of US adults, our analysis in US NHANES 
considered the oversampling, stratification, and 
clustering according to the NHANES statistical analysis 
guideline.39 Baseline characteristics were described 
across different levels of SES, and differences among 
groups were tested by analysis of variance adjusted for 
sampling weights for continuous variables and Rao-
Scott χ2 test for categorical variables in US NHANES, 
and by analysis of variance and χ2 test in UK Biobank.
We used Cox proportional hazard regression models 
to estimate the hazard ratios and 95% confidence 
intervals of outcomes associated with SES and lifestyle 
score. The proportional hazards assumption was 
examined by creating a product term of follow-up time 
and SES, and we found no significant deviation from 
the assumption.40 Person years were calculated from 
baseline until the date of death or diagnosis (for the 
incident CVD analysis), or end of follow-up, whichever 
occurred first. Based on previous researches,20 23 
model 1 included SES; age; sex; self-reported race; 
marital status (US NHANES only); assessment centers 
(UK Biobank only); acculturation; BMI; and history 
of hypertension, diabetes, CVD, cancer, chronic 
bronchitis, emphysema, or chronic obstructive 
pulmonary disease. Model 2 additionally included the 
healthy lifestyle score. We used the difference method 
to calculate the mediation proportion by the mediator 
(overall lifestyle) for the association between SES and 
each outcome—that is, comparing estimates from 
models with and without the hypothesized mediator.41 
We additionally calculated the C statistics of the two 
models to compare the predictions with versus without 
the healthy lifestyle score.
We further conducted a stratified analysis by latent 
class of SES to investigate associations of the lifestyle 
score with health outcomes among adults in different 
socioeconomic subgroups. As only 838 (2.2%) and 
3495 (9.4%) US adults had 0 and 4 points of healthy 
lifestyle score, and the corresponding numbers in the 
UK Biobank were 49 545 (12.4%) and 9841 (2.5%), we 
merged participants with 0 points and 1 point as well 
as those with 3 and 4 points to increase the statistical 
power. In this analysis, the reference group was set 
as the participants with unhealthy lifestyles (lifestyle 
scores of 0 or 1), and we examined whether adherence 
to healthy lifestyles was associated with protection 
against mortality and incident CVD across different SES 
subgroups. To quantify the additive and multiplicative 
interactions, we additionally included a product term 
of SES (low, medium, and high) and healthy lifestyle 
score (0 or 1; 2; and 3 or 4 points) in the model. The 
hazard ratio with its 95% confidence interval of the 
product term was the measure of interaction on the 
multiplicative scale. We used the relative excess risk 
due to interaction (RERI) and corresponding 95% 
confidence intervals as the measure of interaction on 
the additive scale, calculated using the coefficients 
and corresponding standard errors of the product term, 
SES, and lifestyle score, as well as covariance matrix.42
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To assess the joint associations, we further classified 
participants into nine groups according to SES (low, 
medium, and high) and healthy lifestyle score (0 or 
1; 2; and 3 or 4 points) and estimated hazard ratios 
of mortality and incident CVD in different groups 
compared with those with high SES and three or four 
healthy lifestyle factors.
To test the robustness and potential variations in 
different subgroups, we repeated all analyses stratified 
by sex (men and women), self-reported race (white and 
non-white participants), and age groups (<60, and ≥60, 
defined as elders by the World Health Organization43).
We conducted several sensitivity analyses. First, 
we repeated all analyses by substituting SES with 
each socioeconomic factor (ie, family income level, 
occupation or employment status, education level, 
and health insurance), and these factors were 
mutually adjusted in the models. Similarly, we also 
used the individual lifestyle factors instead of the 
score in the models to evaluate whether the estimated 
mediation proportion was similar to that of the main 
analysis. Second, a weighted healthy lifestyle score 
was constructed to account for varied magnitudes of 
the associations between different lifestyle factors 
and outcomes.44 Third, we constructed a lifestyle 
score including baseline BMI. Fourth, we excluded 
individuals with prevalent diabetes, CVD, cancer, 
chronic bronchitis, emphysema, or chronic obstructive 
pulmonary disease because both lifestyles and SES 
could be influenced by major chronic diseases. Fifth, 
we excluded events that occurred within the first 
three years of follow-up to reduce potential reverse 
causation. Sixth, we restricted the analysis to those 
aged 40 years or older in US NHANES to coincide with 
the age distribution in UK Biobank, and to reduce the 
concern that SES is prone to change and the risk of 
mortality due to lifestyles is relatively lower in younger 
adults. As only five participants in UK Biobank were 
aged less than 40 years, this sensitivity analysis was 
not performed in UK Biobank. Seventh, we used 
multiple imputation to impute all missing independent 
variables to test the influence of missing variables.45 
Eighth, we assigned 0, 1, and 2 points to each low, 
medium, and high level socioeconomic factor (for 
employment status in UK Biobank, only 0 and 2 points 
were assigned for unemployed and employed status) 
and added the scores to get a socioeconomic score 
(range 0-8 in US NHANES and 0-6 in UK Biobank). As 
only 756 (0.9%) participants in US NHANES and 5000 
(1.3%) in UK Biobank had a score of 0, we merged those 
with 0 or 1 point. The socioeconomic score was then 
used in all analyses instead of the latent class derived 
SES variable. Ninth, in the final model in UK Biobank 
we further included the Townsend deprivation index, a 
variable reflecting the area level SES, for two purposes: 
to evaluate whether the association between individual 
level SES and health outcomes remained robust when 
controlling for area level SES, and to repeat all the main 
analysis using Townsend deprivation index as the SES 
variable, instead of the individual level SES variable. 
Tenth, we additionally included quadratic terms of 
age in the models to consider the possible non-linear 
associations of age with health outcomes.
All analyses were performed using SAS version 9.4 
(SAS Institute, Cary, NC). We considered two sided P 
values <0.05 to be significant.
Patient and public involvement
The analyses were based on existing data of two cohort 
studies in general populations, US NHANES and UK 
Biobank, and we did not participate in the participant 
recruitment. To our knowledge, no patients were 
involved in the design, recruitment, or conduct of the 
studies. The research question and outcome measures 
of the present study were proposed by systematically 
reviewing the evidence of the associations between 
lifestyles and non-communicable diseases, and no 
patients were involved in the process. Participants 
from the two cohorts were deidentified, and thus we 
could not disseminate the results to each participant; 
however, the results will be disseminated to the public 
through broadcasts and popular science articles.
Results
Population characteristics
Table 1 shows baseline characteristics of participants 
from US NHANES and UK Biobank. Among 44 462 
participants from US NHANES (mean age 46.5 years, 
48.7% men), 10 469 (33.6%) were of high SES, 20 729 
(46.4%) of medium SES, and 13 264 (20.0%) of low 
SES. Among 399 537 participants from UK Biobank 
(mean age 56.1 years, 47.5% men), 79 697 (19.9%) 
were of high SES, 210 935 (52.8%) of medium SES, 
and 108 905 (27.3%) of low SES. Adults of low SES 
were more likely to be women, non-white people, 
not married, unemployed, and less educated, and to 
have low income, public or no health insurance, and 
a higher prevalence of comorbidities. Unhealthy levels 
of cigarette smoking, leisure time physical activity, 
and BMI were more prevalent among adults of low 
SES. Participants excluded from the current analysis 
owing to missing information were older, of low SES, 
and more likely to be women, non-white people, not 
married, and less accultured (see supplementary 
table 3).
Mediation analysis of lifestyle on associations of 
SES with mortality and incident CVD
In US NHANES, 8906 deaths were recorded (1889 
from heart disease) during a mean follow-up of 11.2 
years. In UK Biobank, 22 309 deaths (4537 from 
CVD; a mean follow-up of 11.0 years) and 6903 
incident CVD cases (4414 myocardial infarction and 
2645 stroke; a mean follow-up of 8.8 years) were 
recorded. After adjusting for lifestyle score and other 
covariates, including age, sex, self-reported race, 
marital status, assessment centers, acculturation, 
BMI, and history of comorbidities, the hazards ratios 
when adults of low SES were compared with adults 
of high SES were 2.13 (95% confidence interval 1.90 
to 2.38) for all cause mortality in US NHANES, and 
1.96 (1.87 to 2.06) for all cause mortality, 2.25 (2.00 
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to 2.53) for CVD mortality, and 1.65 (1.52 to 1.79) 
for incident CVD in UK Biobank (table 2). The hazard 
ratios without adjustment for lifestyle score were 
larger. Each additional healthy lifestyle factor was 
associated with 11% to 17% lower risks of mortality 
and incident CVD (supplementary table 4). When 
low SES was compared with high SES, the proportion 
mediated by the lifestyle score was 12.3% (10.7% to 
13.9%) for all cause mortality in US NHANES, and 
4.0% (3.5% to 4.4%) for all cause mortality, 3.0% 
(2.5% to 3.6%) for CVD mortality, and 3.7% (3.1% to 
4.5%) for incident CVD in UK Biobank (table 2). When 
the socioeconomic score was used to investigate more 
extreme socioeconomic disparities, the hazard ratios 
for the lowest compared with highest socioeconomic 
score were 2.87 and 3.23 for all cause mortality 
Table 1 | Baseline characteristics of participants from US National Health and Nutrition Examination Survey (US NHANES) and UK Biobank according to 
socioeconomic status (SES).* Values are numbers (percentages) unless stated otherwise
Characteristics


















Mean age (95% CI) 
(years)
46.5 (46.1 to 
46.9)
45.9 (45.3 to 
46.4)
47.7 (47.2 to 
48.2)
44.8 (44.2 to 
45.3) 56.1 (56.1 to 56.1)
52.5 (52.4 to 
52.5) 55.7 (55.7 to 55.8) 59.5 (59.5 to 59.5)
Men 21 869 (48.7) 5335 (50.9) 10 357 (48.4) 6177 (45.8) 189 813 (47.5) 40 990 (51.4) 101 484 (48.1) 47 339 (43.5)
White ethnicity or race 21 392 (73.6) 6630 (84.0) 10 878 (76.0) 3884 (50.8) 382 053 (95.6) 76 596 (96.1) 202 429 (96.0) 103 028 (94.6)
Married 24 223 (57.4) 6987 (68.7) 11 860 (58.1) 5376 (37.0) - - - -
Household income§:
 High 10 840 (34.6) 8162 (81.0) 2653 (15.9) 25 (0.3) 105 098 (26.3) 78 565 (98.6) 25 914 (12.3) 619 (0.6)
 Medium 24 629 (52.0) 2176 (18.0) 17 208 (80.3) 5245 (43.1) 206 809 (51.8) 1132 (1.4) 185 021 (87.7) 20 656 (19.0)
 Low 8993 (13.4) 131 (1.0) 868 (3.7) 7994 (56.6) 87 630 (21.9) 0 0 87 630 (80.5)
Occupation:
  Employed, student, or 
retired 35 382 (81.7) 9787 (92.8) 18 637 (89.1) 6958 (46.2) 372 167 (93.1) 75 242 (94.4) 207 951 (98.6) 88 974 (81.7)
  Upper socioeconomic 
index 7267 (22.7) 6325 (61.2) 697 (3.8) 245 (2.1)
- - - -
 Lower socioeconomic 
index 28 115 (59.0) 3462 (31.6) 17 940 (85.3) 6713 (44.1)
- - - -
 Unemployed 9080 (18.3) 682 (7.2) 2092 (11.0) 6306 (53.8) 27 370 (6.9) 4455 (5.6) 2984 (1.4) 19 931 (18.3)
Education:
 College or above 19 747 (55.1) 10 152 (96.6) 7394 (39.1) 2201 (22.4) 188 002 (47.1) 63 753 (80.0) 97 653 (46.3) 26 596 (24.4)
  High school or  
equivalent 11 511 (26.4) 317 (3.4) 8750 (44.7) 2444 (22.8) 153 752 (38.5) 15 944 (20.0) 103 822 (49.2) 33 986 (31.2)
 Less than high school 13 204 (18.5) 0 4585 (16.2) 8619 (54.8) 57 783 (14.5) 0 9460 (4.5) 48 323 (44.4)
Health insurance:
 Private 26 795 (68.8) 9278 (90.4) 16 448 (79.6) 1069 (7.5) - - - -
 Public only 8907 (14.5) 745 (5.7) 1896 (7.8) 6266 (44.9) - - - -
 None 8760 (16.6) 446 (4.0) 2385 (12.5) 5929 (47.6) - - - -
More accultured 37 584 (91.5) 9818 (96.1) 18 466 (93.2) 9300 (79.6) 367 865 (92.1) 71 696 (90.0) 196 119 (93.0) 100 050 (91.9)
Never smoking 22 835 (50.5) 6330 (59.7) 10 369 (47.8) 6136 (41.6) 218 975 (54.8) 49 681 (62.3) 117 780 (55.8) 51 514 (47.3)
No heavy alcohol  
consumption 41 747 (92.3) 9817 (92.5) 19 535 (92.6) 12 395 (91.3) 251 900 (63.0) 45 264 (56.8) 131 045 (62.1) 75 591 (69.4)
Top third of LTPA 12 956 (34.0) 4507 (45.6) 5824 (30.4) 2625 (22.6) 133 182 (33.3) 32 993 (41.4) 71 688 (34.0) 28 501 (26.2)
Healthy diet¶ 19 321 (43.6) 5534 (52.5) 8803 (41.0) 4984 (34.9) 56 892 (14.2) 10 826 (13.6) 29 278 (13.9) 16 788 (15.4)
BMI:
 18.5-24.9 13 827 (33.4) 3568 (36.2) 6443 (32.6) 3816 (30.6) 131 018 (32.8) 31 920 (40.1) 68 872 (32.7) 30 226 (27.8)
 <18.5 755 (1.8) 149 (1.4) 309 (1.7) 297 (2.7) 1998 (0.5) 388 (0.5) 926 (0.4) 684 (0.6)
 25.0-29.9 15 294 (33.4) 3684 (34.8) 7163 (33.3) 4447 (31.3) 170 781 (42.7) 33 504 (42.0) 91 756 (43.5) 45 521 (41.8)
 ≥30.0 14 586 (31.4) 3068 (27.6) 6814 (32.5) 4704 (35.4) 95 740 (24.0) 13 885 (17.4) 49 381 (23.4) 32 474 (29.8)
Self-reported  
comorbidities:
 Hypertension 14 746 (29.4) 2864 (24.9) 7171 (31.2) 4711 (32.8) 112 082 (28.1) 15 123 (19.0) 56 087 (26.6) 40 872 (37.5)
 Diabetes 4680 (7.6) 653 (4.7) 2116 (8.2) 1911 (11.2) 19 819 (5.0) 2178 (2.7) 8966 (4.3) 8675 (8.0)
 CVD 4609 (8.1) 597 (4.3) 2232 (8.9) 1780 (12.7) 75 020 (18.8) 8974 (11.3) 35 280 (16.7) 30 766 (28.3)
 Cancer 4048 (9.2) 1034 (9.7) 2160 (9.7) 854 (7.3) 33 816 (8.5) 5252 (6.6) 17 121 (8.1) 11 443 (10.5)
  Emphysema, chronic 
bronchitis, or COPD 3238 (7.6) 474 (4.6) 1502 (7.7) 1262 (12.2) 8847 (2.2) 813 (1.0) 3631 (1.7) 4403 (4.0)
BMI=body mass index; COPD=chronic obstructive pulmonary disease; CVD=cardiovascular disease; LTPA=leisure time physical activity.
*In US NHANES, all estimates accounted for complex survey designs, and P values were calculated using analysis of variance adjusting for sampling weights and Rao-Scott χ2 test for continuous 
and categorical variables, respectively. In UK Biobank, P values were calculated using analysis of variance and χ2 test for continuous and categorical variables, respectively. All P values were 
<0.001, except for heavy alcohol consumption (P=0.058).
†SES in US NHANES was generated through latent class analysis using information on family income to poverty ratio, occupation, education level, and health insurance.
‡SES in UK Biobank was generated through latent class analysis using the information on household income, employment status, and education level.
§In US NHANES, ≥4, >1 to <4, and ≤1 of family income to poverty ratios represented the high, medium, and low family income level, respectively. In UK Biobank, <£18 000 ($25 000; €21 000), 
£18 000-£51 999, and ≥£52 000 of average total household income before tax represented the high, medium, and low family income level, respectively.
¶In US NHANES III, healthy diet denoted the top two fifths of healthy eating index-1995 score. In the continuous US NHANES, healthy diet denoted the top two fifths of healthy eating index-2015 
score. In UK Biobank, healthy diet denoted ideal intakes of ≥5 dietary components for cardiovascular health.
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in US NHANES and UK Biobank, respectively, and 
3.37 for CVD mortality and 2.46 for incident CVD 
in UK Biobank. However, the mediation proportion 
attributed to lifestyle remained similar to that of the 
main analyses (supplementary table 5). Additional 
inclusion of the healthy lifestyle score did not improve 
the prediction of all outcomes (supplementary 
table 6).
When low SES levels were compared with high 
SES levels, each individual socioeconomic factor 
was associated with higher risks of all primary 
outcomes, and the hazard ratios ranged from 1.13 to 
2.09 (supplementary table 7). The proportion of the 
association between individual socioeconomic factors 
and mortality mediated by lifestyles ranged from 
less than 1% for household income in UK Biobank to 
22.2% for education attainment in both cohorts. When 
the Townsend deprivation index was simultaneously 
included in the final model in UK Biobank, the 
associations of individual level SES with primary 
outcomes were not materially changed. In general, 
the associations between Townsend deprivation index 
and health outcomes were weaker compared with 
individual level SES (supplementary fig 2). Results 
of all sensitivity analyses were largely consistent, 
except that the mediation proportion increased 
when the healthy lifestyle score was substituted 
by four individual lifestyle factors in UK Biobank 
(supplementary table 5).
Supplementary table 8 shows the results for the 
mortality and morbidity of CVD subtypes. The hazard 
ratios when low SES was compared with high SES 
ranged from 1.45 for incident stroke to 2.62 for 
coronary heart disease mortality, and the mediation 
proportion by lifestyle ranged from 2.8% to 8.2%.
Interaction and joint analysis of lifestyle and SES 
with mortality and incident CVD
No significant interaction was found between lifestyle 
and SES on all cause mortality in US NHANES, whereas 
both multiplicative and additive interactions were 
observed between lifestyle and SES on all primary 
outcomes in UK Biobank (all P for interaction <0.02; 
fig 1). A healthier lifestyle score was associated with 
lower risks of all primary outcomes among individuals 
of various SES subgroups in both cohorts, whereas the 
associations were stronger among those from a low 
SES subgroup in UK Biobank (fig 1). For example, in 
UK Biobank, the hazard ratios for those with three or 
four healthy lifestyle factors compared with no or one 
healthy lifestyle factor for all cause mortality were 
0.86 (0.76 to 0.96) among individuals of high SES, 
0.70 (0.66 to 0.74) among those of medium SES, and 
0.56 (0.52 to 0.59) among those of low SES. Similar 
patterns were found for total CVD mortality and 
incident CVD (fig 1), and when CVD subtypes were 
used as the outcomes (supplementary fig 3), as well 
as when the area level Townsend deprivation index 
was used as the SES variable (supplementary fig 2). 
The results remained similar in all sensitivity analyses 
(supplementary table 9).
Figure 2 shows the joint association of lifestyles and 
SES on the primary outcomes, and hazard ratios for 
individuals of low SES and no or one healthy lifestyle 
factor compared with those with high SES and three or 
four healthy lifestyle factors were 3.53 (3.01 to 4.14) 
for all cause mortality in US NHANES, and 2.65 (2.39 
to 2.94) for all cause mortality, 2.65 (2.09 to 3.38) for 
CVD mortality, and 2.09 (1.78 to 2.46) for incident 
CVD in the UK Biobank. Results were not materially 
changed in all sensitivity analyses (supplementary 
Table 2 | Associations of socioeconomic status (SES) with incident cardiovascular disease (CVD) and mortality and 
mediation proportion of socioeconomic inequity in health attributed to lifestyle*
Hazard ratio (95% CI) Mediation proportion (%)  
(95% CI)Unadjusted for lifestyle score Adjusted for lifestyle score
All cause mortality
US NHANES:
 High SES 1 (Reference) 1 (Reference) -
 Medium SES 1.67 (1.51 to 1.84) 1.57 (1.42 to 1.73) 11.9 (9.6 to 14.2)
 Low SES 2.36 (2.11 to 2.65) 2.13 (1.90 to 2.38) 12.3 (10.7 to 13.9)
UK Biobank:
 High SES 1 (Reference) 1 (Reference) -
 Medium SES 1.31 (1.25 to 1.37) 1.29 (1.23 to 1.35) 5.1 (4.0 to 6.5)
 Low SES 2.02 (1.92 to 2.12) 1.96 (1.87 to 2.06) 4.0 (3.5 to 4.4)
CVD in UK Biobank
CVD mortality:
 High SES 1 (Reference) 1 (Reference) -
 Medium SES 1.33 (1.19 to 1.49) 1.31 (1.17 to 1.47) 4.6 (2.8 to 7.2)
 Low SES 2.31 (2.06 to 2.59) 2.25 (2.00 to 2.53) 3.0 (2.5 to 3.6)
Incident CVD:
 High SES 1 (Reference) 1 (Reference) -
 Medium SES 1.29 (1.20 to 1.39) 1.28 (1.18 to 1.38) 4.1 (2.8 to 5.9)
 Low SES 1.69 (1.55 to 1.83) 1.65 (1.52 to 1.79) 3.7 (3.1 to 4.5)
US NHANES=US National Health and Nutrition Examination Survey.
*SES was generated through latent class analysis using information on family income to poverty ratio, occupation, education, and health insurance in US 
NHANES, and household income, education, and employment status in UK Biobank. All models included age, sex, marital status (US NHANES only), self-
reported race, acculturation, study center (UK Biobank only), body mass index, and prevalent comorbidities (including history of hypertension, diabetes, 
CVD, cancer, chronic bronchitis, emphysema, or chronic obstructive pulmonary disease). The healthy lifestyle score consisted of never smoking, no heavy 
alcohol consumption, higher physical activity level, and a higher diet quality score. Analysis in US NHANES included the US population and study design 
weights to account for the complex survey design. Only those free from CVD at baseline were included in the analysis for incident CVD.
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Hazard ratio for product term 0.97 (95% CI 0.67 to 1.39) P=0.85
RERI 0.40 (95% CI -0.12 to 0.93) P=0.13
Hazard ratio for product term 1.30 (95% CI 1.05 to 1.62) P=0.016
RERI 0.55 (95% CI 0.32 to 0.78) P<0.001
















































































Hazard ratio for product term 1.53 (95% CI 1.34 to 1.75) P<0.001
RERI 1.01 (95% CI 0.88 to 1.14) P<0.001
Hazard ratio for product term 1.65 (95% CI 1.21 to 2.24) P=0.002


























































































Fig 1 | Associations of healthy lifestyle score with mortality and incident cardiovascular disease (CVD) by 
socioeconomic status (SES). In the US National Health and Nutrition Examination Survey (US NHANES), models 
included US population and study design weights to account for the complex survey design. Hazard ratios were 
adjusted for age, sex, marital status (US NHANES only), self-reported race, acculturation, study center (UK Biobank 
only), body mass index, and prevalent comorbidities (including history of hypertension, diabetes, CVD, cancer, 
chronic bronchitis, emphysema, or chronic obstructive pulmonary disease). Only those free from CVD at baseline were 
included in the analysis for incident CVD. Multiplicative interaction was evaluated using hazard ratios for the product 
term between the healthy lifestyle score (0 or 1 point v 3 or 4 points) and SES (low v high), and the multiplicative 
interaction was statistically significant when its confidence interval did not include 1. Additive interaction was 
evaluated using relative excess risk due to interaction (RERI) between the healthy lifestyle score (0 or 1 point v 3 or 4 
points) and SES (low v high), and the additive interaction was statistically significant when its confidence interval did 
not include 0
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table 10), and similar patterns were found when 
using individual socioeconomic factors in the analysis 
(supplementary fig 4), as well as when using the area 
level Townsend deprivation index in the UK Biobank 
(supplementary fig 2).
Lifestyle and socioeconomic inequity in health 
among subpopulations
Supplementary tables 11 and 12 and supplementary 
figure 5 show results stratified by sex, self-reported 
race, and age group. The socioeconomic inequity in all 
cause mortality and the joint associations of lifestyles 
and SES with all cause mortality were stronger in men 
than in women, and in younger than older adults in 
both cohorts (P for interaction <0.03). The results 
were not substantially different between white and 
non-white people. The proportions of socioeconomic 
inequity in health mediated by lifestyles were all 
modest (all <20%; data not shown) and similar to 
those of the main analyses.
Discussion
In these two large US and UK cohorts, low SES was 
associated with higher risks of mortality and CVD, and 
3.0% to 12.3% of the associations were mediated by 
lifestyle factors. In UK Biobank, significant interactions 
were found between lifestyle factors and SES on all 
primary outcomes, and the associations between 
lifestyle factors and health outcomes were stronger 
among those of low SES. The highest risks of mortality 
and CVD were seen in adults of low SES and with the 
least healthy lifestyles.
Comparison with other studies
Socioeconomic inequity in mortality has been widely 
discussed. A large multicohort study with 1.7 million 
participants from the US, Europe, and Australia found 
that low SES was associated with a 26% higher risk of 
mortality and 2.1 years of life lost between ages 40 and 
85 years, and low SES might respectively contribute to 
15.3% and 18.9% of deaths among women and men.1 
Moreover, socioeconomic inequity in mortality has 
continuously widened in the US. From 2001 to 2014, 
longevity increased by 2.34 and 2.91 years, respectively, 
among the wealthiest 5% of US men and women, whereas 
only 0.32 and 0.04 years among the poorest 5% of US 
men and women.46 Similar trends were also observed in 
the UK, or when high education levels were compared 
with low education levels.23 Our analysis confirmed the 
socioeconomic disparity in mortality and extended the 
findings to CVD morbidity and mortality. Thus, exploring 
the possible methods to reduce socioeconomic inequity 
in health is urgently needed.
The current evidence indicates causal relations 
between SES and death,47 and SES could affect 
individuals’ access to multitudinous resources (eg, 
knowledge, wealth, power, prestige, and advantageous 
social connections) and protective factors (eg, healthy 
lifestyle and healthcare services). Many studies have 
investigated the contribution of health behaviors to 
socioeconomic inequity in health outcomes, including 
mortality and CVD. A systematic review of 31 studies6 
reported that about 20% to 30% of the socioeconomic 
inequity in health outcomes were explained by 
lifestyle factors. However, substantial heterogeneity 
was reported, with a minimum of −59% to a maximum 
of 75%. Therefore, firm conclusions cannot be made, 
and there are several potential reasons why this is 
not possible. First, most studies investigated a single 
socioeconomic factor, and studies examining an 
overall individual level SES were limited. Although 
different socioeconomic factors might correlate with 
each other, they reflected different domains of SES 
or social class and should not be simply replaced 
by others. Second, most previous studies examined 
single or limited numbers of lifestyle factors, and only 
five studies considered all lifestyle factors (smoking, 
alcohol consumption, physical activity, and diet) in 
the models.48-52 Third, the characteristics of study 
populations (eg, age, sex composition, race or ethnicity, 
regions, SES levels, health status), study design (cross 
sectional or longitudinal, and follow-up duration if a 
cohort study), data collection methods, and statistical 
methods (such as adjustment for covariates) varied 
widely.
Our study found that in US and UK adults only 
up to 12.3% of the association between SES and 
mortality was explained by lifestyle factors. The 
results are consistent with several other studies in 
various populations.53-55 In the longitudinal analyses 
on 22 194 participants in the Moli-sani study, Italy, 
participants of poor SES in childhood (assessed by a 
score of three variables: housing tenure, access to hot 
water, and overcrowding in household) but an upward 
trajectory in both education attainment and material 
circumstances had lower risks of total and cause 
specific mortality, whereas health related behaviors 
explained less than 10% of the association.56 The 
low mediation proportion indicated that substantial 
reductions of the socioeconomic inequity in health 
could not be achieved through promoting healthy 
lifestyles alone, and other measures to tackle the social 
determinants of health are still needed.
In our study, we also confirmed that healthy lifestyles 
were associated with lower risks of mortality and 
incident CVD in the two cohorts, regardless of SES. In 
addition, significant interactions were observed in the 
UK study, and the protective associations of healthy 
lifestyles and health outcomes were stronger among 
those of low SES, which highlighted the necessity of 
lifestyle modification, especially among those of low 
SES who were more vulnerable to unhealthy lifestyles. 
This is consistent with a previous analysis in the UK 
Biobank study,20 which also found that combinations 
of unhealthy lifestyle factors were associated with 
disproportionate harm in deprived populations, as 
assessed by the Townsend deprivation index, an area 
level SES variable. However, we found no significant 
interaction between lifestyles and SES on total mortality 
in the US study, similar to an analysis of education 
attainment and lifestyles with CVD mortality in Japan.57 
Another study in a generally low income population 
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Fig 2 | Joint associations of healthy lifestyle score and socioeconomic status with mortality and incident cardiovascular disease (CVD). In the US 
National Health and Nutrition Examination Survey (US NHANES), models included US population and study design weights to account for the 
complex survey design. Hazard ratios were adjusted for age, sex, marital status (US NHANES only), self-reported race, acculturation, study center 
(UK Biobank only), body mass index, and prevalent comorbidities (including history of hypertension, diabetes, CVD, cancer, chronic bronchitis, 
emphysema, or chronic obstructive pulmonary disease). Only those free from CVD at baseline were included in the analysis for incident CVD
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in the US even found a weaker association between 
lifestyles and mortality among men with relatively low 
incomes, but not among women.44 The exact reasons 
for the inconsistent findings were unclear, but might 
depend on the definition of SES and lifestyle factors 
as well as the population characteristics. More studies 
are still needed to understand the complex relations 
between lifestyle factors and SES on health.
We also compared the overall individual level SES 
variable and Townsend deprivation index in the UK 
Biobank and found that the associations of individual 
level SES with outcomes were stronger than those of 
area level SES, and similar patterns were observed 
for the joint associations of lifestyle factors and SES. 
Besides, effect sizes of individual level SES were not 
attenuated after adjusting for Townsend deprivation 
index. Accordingly, it is necessary to construct an 
overall individual level SES variable because postcode 
derived area level SES reflects different aspects and has 
several problems, such as inability to determine social 
causes of health, inability to distinguish individual 
differences, confusion with other environmental health 
determinants, unreliability when populations are 
heterogeneous or change quickly, and inapplicability 
to mobile communities.58
Strengths and limitations of this study
Major strengths of this study are the large sample size 
from two well established nationwide cohorts in the US 
and UK—the findings are generally consistent within 
the two cohorts except for the interaction between 
lifestyle factors and SES on health outcomes. The large 
sample size also allowed us to perform the joint and 
stratified analyses with sufficient statistical power. In 
addition, we constructed an overall SES variable and 
healthy lifestyle score to comprehensively evaluate 
the complex relations of lifestyle factors and SES with 
mortality and incident CVD. We also conducted a series 
of sensitivity analyses to show the robustness of the 
findings, and evaluated individual socioeconomic and 
lifestyle factors.
Nevertheless, we also acknowledge several limi-
tations. First, information on socioeconomic level 
and lifestyle was mainly self-reported and was only 
measured once, thus measurement errors were 
inevitable. Besides, we could not capture the long term 
SES trajectories as well as lifestyle changes during 
adulthood. Future studies with repeated measurements 
are preferred. Second, the SES variable was constructed 
differently in the two cohorts. For example, health 
insurance scheme was included as a component in the 
US study but not in the UK study, and occupational 
information was not collected at baseline in the UK 
Biobank and thus we could only use employment 
status. Third, a lifestyle score derived from a sum of 
the number of healthy lifestyle factors assumed that all 
lifestyle factors had equal effects on health outcomes, 
which might not be true. Although we constructed a 
weighted lifestyle score in the sensitivity analysis and 
found similar results, the weighted score still cannot 
fully account for the complex interactions between 
lifestyle factors, and the weights were study specific. 
Fourth, the follow-up duration is relatively short (mean 
8.8-11.2 years), and those who died during the study 
period might have had serious diseases at baseline. 
Both lifestyle behaviors and SES could be influenced by 
disease status. Although our main analysis of adjusting 
comorbidities at baseline and sensitivity analysis of 
excluding those with major chronic diseases at baseline 
generated robust results, the possibility of reverse 
causation and residual confounding (many other 
diseases were not measured or considered) cannot be 
fully eliminated. Fifth, those excluded from the analysis 
because of missing covariates were more likely to be 
of lower SES; therefore, the socioeconomic inequity 
in health outcomes might be underestimated in our 
study. Nevertheless, the results remained similar after 
imputing missing covariates. Sixth, owing to the nature 
of post hoc subgroup analyses, sample size in each 
subgroup was not calculated before data collection. 
Especially, the number of participants and events 
might be insufficient among the non-white subgroup in 
the UK Biobank, and the results should be cautiously 
interpreted. Finally, although we controlled for key 
personal characteristics and comorbidities, residual 
confounding was still possible and causal inference 
cannot be made because of the nature of observational 
studies.
Conclusions
Based on two large nationwide US and UK cohorts, 
low SES was found to be significantly associated 
with higher risks of mortality and incident CVD, and 
the associations were modestly mediated by lifestyle 
factors. Therefore, promoting healthy lifestyles alone 
might not substantially reduce the socioeconomic 
inequity in health without other social determinants 
of health being considered. The finding argues for 
government policies to tackle upstream social and 
environmental determinants of health.59 Nevertheless, 
individuals with disadvantaged SES and unhealthy 
lifestyles had the highest risks of mortality and 
incident CVD, which highlights the importance of 
lifestyle modification in reducing disease burden for 
all people, especially those of low SES in the UK.
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